Intervention guidelines for neonatal hyperbilirubinemia: An evidence based quagmire

Current Pharmaceutical Design

Volumn 15, Issue 25, 2009, Pages 2939-2945

  Wennberg, Richard P ^a   Ahlfors, Charles E ^a   Aravkin, Aleksandr Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

American Academy of Pediatrics guidelines; Bilirubin; Bilirubin photoisomers; Free bilirubin; Hyperbilirubinemia; Kernicterus; Unbound bilirubin

Indexed keywords

BILIRUBIN;

ASTROCYTE; BILIRUBIN BLOOD LEVEL; BINDING SITE; BLOOD BRAIN BARRIER; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FALSE POSITIVE RESULT; GENETIC VARIABILITY; HEARING IMPAIRMENT; HUMAN; INCIDENCE; ISOMER; KERNICTERUS; NEUROLOGIC DISEASE; NEWBORN JAUNDICE; NONHUMAN; OXIDATION; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS;

BILIRUBIN; BIOLOGICAL MARKERS; BIOLOGICAL TRANSPORT; CONFOUNDING FACTORS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; FALSE POSITIVE REACTIONS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; KERNICTERUS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 70449399269     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161209789058228     Document Type: Review

References (80)

1. Volpe JJ. Bilirubin and brain injury. In: Volpe JJ, Ed. Neurology of the Newborn. Philadelphia: WB Saunders 2001; pp. 490-514.
2. Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol 2006; 33: 387-410.
3. Wennberg RP, Ahlfors CE, Bickers R, McMurtry CA, Shetter JL. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: Improvement with exchange transfusion. J Pediatr 1982; 100: 624-626.
4. Perlman M, Fainmesser P, Sohmer H, Tamari H, Wax Y, Pevsmer B. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics 1983; 72: 658-664. (Pubitemid 14232886)
5. Lenhardt ML, McArter R, Bryant B. Effects of neonatal hyperbilirubinemia on the brainstem electric response. J Pediatr 1984; 104: 281-284. (Pubitemid 14188945)
6. Vohr BR, Kapr D, O'Dea C, Darrow D, Coll CG, Lester BM, et al. Behavioral changes correlated with brain-stem auditory evoked responses in term infants with moderate hyperbilirubinemia. J Pediatr 1990; 117: 288-291. (Pubitemid 20238548)
7. Yilmaz Y, Degirmenci S, Akdas F, Kulekci S, Ciprut A, Yudsel S, et al. Prognostic value of auditory brainstem response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 2001; 16: 772-775. (Pubitemid 33150170)
8. Perlstein MA. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 1960; 7: 665-687.
9. Chisin R, Perlman M, Sohmer H. Cochlear and brain stem responses in hearing loss following neonatal hyperbilirubinemia. Ann Otol 1979; 88: 352-1257 (Pubitemid 9208665)
10. Berlin CI, Morlet T, Hood LJ. Auditory neuropathy/dyssynchrony: its diagnosis and management. Pediatr Clin North Am 2003; 50: 331-340. (Pubitemid 36666560)
11. Berg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE. Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics 2005; 116: 933-938. (Pubitemid 44542821)
12. American Academy of Pediatrics Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
13. Bhutani VK, Maisels MJ, Stark ARE, Buonocore G, Expert Committee for Severe Neonatal Hyperbilirubinemia; European Society for Pediatric Research; American Academy of Pediatrics. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >or=35 weeks gestation. Neonatology 2008; 94: 63-67.
14. Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS. Readmission for neonatal jaundice in California. Pediatrics 2008; 121: e864-e869.
15. Manning DJ, Maxwell MJ, Todd PJ, Platt MJ. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed 2006; 91: F434-F438.
16. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587-590 (Pubitemid 44439718)
17. Trolle D. Discussion on the advisability of performing exchange transfusion in neonatal jaundice of unknown etiology. Acta Paediatr 1961; 50: 392-398.
18. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, Maisels J, Lau J, Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130-e153.
19. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR, et al. Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650-662. (Pubitemid 39405878)
20. Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics (Suppl) 1999; 104: 736.
21. Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Pediatrics 2003; 111: 1303-1311. (Pubitemid 36682263)
22. Ahlfors CE, Herbsman O. Unbound bilirubin in a term newborn with kernicterus. Pediatrics 2003; 111: 1110-1112. (Pubitemid 36542630)
23. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001; 107: 1075-1080. (Pubitemid 32440614)
24. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, et al. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006: 354: 1889-1900 (Pubitemid 43872690)
25. Seoud I, Khairy MA, Khairy DA. Neonatal Jaundice in Cairo University Pediatric Hospital. J Arab Child 2007; 18: 177-187.
26. Brodersen R, Bartels P. Enzymatic oxidation of bilirubin. Eur J Biochem 1969; 10: 468-473.
27. Hansen TWR, Allen JW. Bilirubin-oxidizing activity in rat brain. Biol Neonate 1996; 70: 289-295.
28. Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med 2004; 10: 65-70.
29. Rigato I, Pascolo L, Fernetti C, Ostrow JD, Tiribelli C. The human mulidrug-resistance-associated protein MRP1 mediates ATP-ependent transport of unconjugated bilirubin. Biochem J 2004; 383: 335-341. (Pubitemid 39446695)
30. Gennuso F, Fernetti C, Tirolo C, Testa N, L'Episcopo F, Caniglia S, et al. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistanceassociated protein 1 (MRP1). Proc Natl Acad Sci USA 2004; 101: 2470-2475. (Pubitemid 38269335)
31. Lin S, Wei X, Bales KR, Paul AB, Ma Z, Yan G, et al. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia- induced cerebellar hypoplasia in the Gunn Rat. Eur J Neurosci 2005; 22: 21-27. (Pubitemid 41059968)
32. Watchko JF, Daood MJ, Mahmood B, Vats K, Hart C, Ahdab- Barmada M. P- glycoprotein and bilirubin disposition. J Perinatol 2001; 21: S43-S47.
33. Hankø E, Tommarello S, Watchko JF, Hansen TW. Administration of drugs known to inhibit P-glycoprotein increases brain bilirubin and alters the regional distribution of bilirubin in rat brain. Pediatr Res 2003; 54: 441-445. (Pubitemid 37159109)
34. Watchko JF, Daood MJ, Hansen TWR. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mutant mice. Pediatr Res 1998; 44: 763-766
35. Nelson T, Jacobsen J, Wennberg RP. Effect of pH on the interaction of bilirubin with albumin and tissue culture cells. Pediatr Res 1974; 8: 963-967.
36. Mediavilla MG, Pascolo L, Rodriguez JV, Guibert EE, Ostrow JD, Tiribelli C. Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration. FEBS Lett 1999; 463: 143-145.
37. Calligaris SD, Bellarosa C, Giraudi P, Wennberg RP, Ostrow JD, Tiribelli C. Cytotoxicity is predicted by unbound and not total bilirubin concentration. Pediatr Res 2007; 62: 576-580. (Pubitemid 351338993)
38. Wennberg RP, Hance AJ. Experimental bilirubin encephalopathy: importance of total bilirubin, protein binding, and blood-brain barrier. Pediatr Res 1986; 20: 789-792.
39. Wennberg RP. Animal models of bilirubin encephalopathy. Adv Vet Sci Comp Med 1993; 37: 87-113.
40. Ahlfors CE, Shapiro SM. Auditory brainstem response and unbound bilirubin in jaundiced (jj) Gun rat pups. Biol Neonate 2001; 80: 158-162.
41. Jacobsen J, Wennberg RP, Determination of unbound bilirubin in the serum of newborns. Clin Chem 1974; 33: 783-789.
42. Nakamura H, Lee Y. Microdetermination of unbound bilirubin in icteric newborn sera: An enzymatic method employing peroxidase and glucose oxidase. Clin Chim Acta 1977; 79: 411-417. (Pubitemid 8168487)
43. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 1994; 93: 50-53. (Pubitemid 24012128)
44. Ahlfors CE, Parker AE. Unbound bilirubin is associated with abnormal automated auditory brainstem responses in jaundiced newborns. Pediatrics 2008; 121: 976-978.
45. Amin SB, Ahlfors C, Orlando MS, Dalzell LE, Merle KS, Guillet R. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 2001; 107: 664. (Pubitemid 32268449)
46. Amin SB. Clinical assessment of bilirubin-induced neurotoxicity in premature infants. Semin Perinatol 2004: 28: 340-347.
47. Nakamura H, Yonetani M, Uetani Y, Funato M, Lee Y. Determination of serum unbound bilirubin for prediction of kernicterus in low birth weight infants. Acta Pediatr Jpn 1992; 34: 642-647. (Pubitemid 23029101)
48. Ritter DA, Kenny JD, Norton J, Rudolph AJ. A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics 1982; 69: 260-266.
49. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth- weight infants. Pediatrics 1982; 69: 481-485.
50. Ahlfors CE, Marshall GD, Wolcott DK, Olson DC, Van Overmeire B. Measurement of unbound bilirubin by the peroxidase test using Zone Fluidics. Clin Chim Acta 2006; 365: 78-85. (Pubitemid 43196419)
51. Ahlfors CE. Effect of serum dilution on apparent unbound bilirubin concentration as measured by the peroxidase method. Clin Chem 1981; 27: 692-696.
52. Weisiger RA, Ostrow JD, Koehler RK, Webster CC, Mukerjee P, PascoloL, et al. Affinity of human serum albumin for bilirubin varies with albumin concentration and buffer composition: results of a novel ultrafiltration method. J Biol Chem 2001; 276: 29953-29960. (Pubitemid 37385068)
53. Roca L, Calligaris S, Wennberg RP, Ahlfors CE, Malik SG, Ostrow JD, et al. Factors affecting the binding of bilirubin to serum albumins: validation and application of the peroxidase method. Pediatr Res 2006; 60: 724-728. (Pubitemid 44789516)
54. Ahlfors CE, Vreman HJ, Wong RJ, Bender GS, OH W, Morris BH, et al. Effects of sample dilution, peroxidase concentration, and chloride ion on the measurement of unbound bilirubin in premature newborns. Clin Biochem 2007; 40: 261-267.
55. Ahlfors CE. Measurement of plasma unbound unconjugated bilirubin. Anal Biochem 2000; 279: 130-135. (Pubitemid 30165000)
56. McDonagh AF, Palma LA, Lightner DA. Phototherapy for neonatal jaundice: stereospecific and regioselective photoisomerization of bilirubin bound to serum albumin and NMR characterization of intramolecularly cyclized photoproducts. J Am Chem Soc 1982; 104: 6867-6869.
57. Onishi S, Isobe K, Itoh S, Manabe M, Sasaki K, Fukuzaki R, et al. Metabolism of bilirubin and its photoisomers in newborn infants during phototherapy. J Biochem 1986; 100: 389-395.
58. Ennever JF, Knox I, Speck WT. Differences in bilirubin isomer composition in infants treated with green and white light phototherapy. J Pediatr 1986; 109: 119-122. (Pubitemid 16099857)
59. Ennever JF, Costarino AT, Polin RA, Speck WT. Rapid clearance of a structural isomer of bilirubin during phototherapy. J Clin Invest 1987; 79: 1674-1678.
60. Agati G, Fusi F, Pratesi S, Galvan P, Donzelli GP. Bilirubin photoisomerization products in urine from a Crigler-Najjar type I patient treated by phototherapy. J Photochem Photobiol B 1998; 47: 181-189. (Pubitemid 29108046)
61. Onishi S, Itoh S, Isobe K, Ochi M, Kunikata T, Imai T. Effect of the binding of bilirubin to either the first class or the second class of binding sites of the serum albumin molecule on its photochemical reaction. Biochem J 1989; 257: 711-714. (Pubitemid 19050127)
62. McDonagh AF. Ex uno plures: the concealed complexity of bilirubin species in nonatal blood samples. Pediatrics 2006; 118: 1185-1187.
63. Lamola AA, Flores J, Blumberg WE. Binding of photobilirubin to human serum albumin; estimate of the affinity constant Eur J Biochem 1983; 132: 165-169.
64. Gulian JM, Delmasso C, Millet V, Unal D, Charrel M. Influence of photoisomers in bilirubin determinations on Kodak Ektachem and Hitachi analyzers in neonatal specimens; study of the contribution of structural and configurational isomers. Eur J Clin Chem Clin Biochem 1995; 33: 503-512.
65. Itoh S, Kawada K, Kusaka T, Yasuda S, Okada H, Imai T, et al. Influence of glucuronosyl bilirubin and (EZ)-cyclobilirubin on determination of serum unbound bilirubin by UB-analyzer. Ann Clin Biochem 2002; 39: 583-588. (Pubitemid 35316291)
66. Itoh S, Yamakawa T, Onishi S, Isobe K, Manabe M, Sasaki K. The effect of bilirubin photoisomers on unbound-bilirubin concentrations estimated by the peroxidase method. Biochem J 1986; 239: 417-421. (Pubitemid 16008462)
67. Hsia DY, Allen FH, Gellis SS, Diamond LK. Erythroblastosis fetalis VIII: Studies of serum bilirubin in relation to kernicterus. N Engl J Med 1952; 247: 668-671.
68. Crosse VM, Obst D. The incidence of kernicterus (not due to haemolyticdisease) among premature babies. In: Sass-Kortsak A, Ed. Kernicterus. Toronto, Canada: University of Toronto Press 1961: 4-9.
69. Hugh-Jones K, Slack J, Simpson K, Grossman A, Hsia DY. Clinical course of hyperbilirubinemia in premature infants. N Engi J Med 1960; 263: 1223-1229.
70. Silverrman WA, Andersen DH, Blanc WA, Crozier DN. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens. Pediatrics 1956; 18: 614-625.
71. Harris RC, Lucey JF, MacLean JR. Kernicterus in premature infants associated with low concentrations of bilirubin in the plasma. Pediatrics 1958; 21: 875-883.
72. Odell GB: Studies in kernicterus I: the protein binding of bilirubin. J Clin Invest 1959; 38: 823-833.
73. Odell GB, Storey GNB, Rosenberg LA. Studies in kernicterus. 3. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr 1970; 76: 12-21.
74. Kaufmann NA, Simeha AJ, Blondheim SH. The uptake of bilirubin by blood cells from plasma and its relationship to the criteria for exchange transfusion. Clin Sci 1967; 33: 201-208.
75. Jirsova V, Jirsa M, Heringova A, Kodovsky O, Weirichova J. The use and possible diagnostic significance of Sephadex gel filtration of serum from icteric newborn. Biol Neonat 1967; 11: 204-208.
76. Lamola AA, Eisinger J, Blumberg WE, Patel SC, Flores J. Fluorometric study of the partition of bilirubin among blood components. Basis for rapid microassays of bilirubin and bilirubin binding capacity in whole blood. Anal Biochem 1979; 100: 25-42.
77. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474-485.
78. Chung HT, Pae HO, Cha YN. Role of heme oxygenase-1 in vascular disease. Curr Pharm Des 2008; 14(5): 422-428
79. Cuadrado A, Rojo AI. Heme oxygenase-1 as a therapeutic target in neurodegenerative diseases and brain infections. Curr Pharm Des 2008; 14(5): 429-442
80. Ferrandiz ML, Devesa I. Inducers of heme oxygenase-1. Curr Pharm Des 2008; 14(5): 473-486